Summary of Key Information:
Reporting Period: Financial Year ended 31st March, 2026
Nature of Filing / Announcement: Outcome of Board Meeting and Audited Financial Results under Regulation 30 and 33 of SEBI Listing Regulations
Audit Opinion:
Unmodified Opinion with emphasis of matter regarding material uncertainty about going concern of one subsidiary
Key Financial Highlights [₹ in Lakhs]:
Standalone Results:
Quarter Ended 31-03-2026:
- Revenue from Operations: 8,220.95 (Q4 FY25: 7,695.45)
- Total Income: 8,804.79 (Q4 FY25: 9,031.96)
- Net Profit: (2,564.61) loss (Q4 FY25: (2,925.11) loss)
- EPS: (4.98) (Q4 FY25: (5.68))
Full Year FY26:
- Revenue from Operations: 1,30,376.89 (FY25: 1,12,156.69) - 16.3% increase
- Total Income: 1,33,454.90 (FY25: 1,17,010.67)
- Net Profit: 28,326.17 (FY25: 26,520.71) - 6.8% increase
- EPS: 55.07 (FY25: 51.56)
- Other Equity: 1,74,048.88 (FY25: 1,46,446.33)
- Cash and Cash Equivalents: 2,937.67 (FY25: 1,538.26)
- Debt: Not Specified
Consolidated Results:
Quarter Ended 31-03-2026:
- Revenue from Operations: 10,711.47 (Q4 FY25: 9,025.20)
- Total Income: 11,293.65 (Q4 FY25: 10,295.01)
- Net Profit: (2,781.30) loss (Q4 FY25: (2,285.72) loss)
- EPS: (6.56) (Q4 FY25: (4.53))
Full Year FY26:
- Revenue from Operations: 1,39,476.26 (FY25: 1,20,497.04) - 15.8% increase
- Total Income: 1,42,406.59 (FY25: 1,25,127.09)
- Net Profit: 29,583.34 (FY25: 28,228.12) - 4.8% increase
- Attributable to Equity Shareholders: 29,584.15 (FY25: 28,132.69)
- EPS: 56.94 (FY25: 55.10)
- Other Equity: 1,74,649.44 (FY25: 1,48,887.09)
- Cash and Cash Equivalents: 4,152.12 (FY25: 2,040.63)
- Debt: Not Specified
Segment-wise Performance:
The company and its subsidiaries are engaged in the business of sale of Seeds & Micronutrients with no other reportable segments under Ind AS 108 "Operating Segments".
Corporate Actions:
No dividend declared for FY26. No other corporate actions like share split, bonus issue, buyback, or capital raising mentioned.
Other Significant Information:
- The company has estimated and recognized the impact of implementation of the New Labour Codes under Employee benefits expense for the year ended 31 March 2026, with impact not material to results
- Figures for quarter ended March 31, 2026 are balancing figures between audited full year and unaudited published year-to-date figures up to December 31, 2025
- One subsidiary has negative net worth of ₹490.64 lakhs and current liabilities exceed current assets by ₹524.72 lakhs, raising material uncertainty about its going concern
- Entities included in consolidation: Aditya Agri Tech Private Limited, Kaveri Microteck Private Limited, Genome Agritech Private Limited, Genome Agri Genetics Private Limited, Kaveri Seed Company Bangladesh Private Limited, Kaveri Employees Trust